149 related articles for article (PubMed ID: 30344738)
21. MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer.
Li Y; Shan Z; Liu C; Yang D; Wu J; Men C; Xu Y
Biochemistry (Mosc); 2017 Apr; 82(4):474-482. PubMed ID: 28371605
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.
Wang S; Chen X; Tang M
Oncol Rep; 2014 Dec; 32(6):2824-30. PubMed ID: 25220761
[TBL] [Abstract][Full Text] [Related]
23. MiR-4644 is upregulated in plasma exosomes of bladder cancer patients and promotes bladder cancer progression by targeting UBIAD1.
Yan L; Li Q; Sun K; Jiang F
Am J Transl Res; 2020; 12(10):6277-6289. PubMed ID: 33194029
[TBL] [Abstract][Full Text] [Related]
24. Signal transducer and activator of transcription 3 regulates CCAAT-enhancer-binding homologous protein expression in osteoblasts through upregulation of microRNA-205.
Zhuang J; Gao R; Wu H; Wu X; Pan F
Exp Ther Med; 2015 Jul; 10(1):295-299. PubMed ID: 26170952
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-125b targeted STAT3 to inhibit laryngeal squamous cell carcinoma cell growth and motility.
Feng J; Fan Y; Ayiheng Q; Zhang H; Yong J; Hu B
Oncol Lett; 2017 Jul; 14(1):480-486. PubMed ID: 28693195
[TBL] [Abstract][Full Text] [Related]
26. MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1.
Chen XN; Wang KF; Xu ZQ; Li SJ; Liu Q; Fu DH; Wang X; Wu B
Cancer Cell Int; 2014; 14():70. PubMed ID: 25414595
[TBL] [Abstract][Full Text] [Related]
27. microRNA-195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription-3 signaling.
Zhao C; Qi L; Chen M; Liu L; Yan W; Tong S; Zu X
Exp Ther Med; 2015 Sep; 10(3):1103-1108. PubMed ID: 26622447
[TBL] [Abstract][Full Text] [Related]
28. microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells.
Tao J; Wu D; Li P; Xu B; Lu Q; Zhang W
Mol Med Rep; 2012 Jan; 5(1):167-72. PubMed ID: 21935572
[TBL] [Abstract][Full Text] [Related]
29. miR‑20b negatively regulates VEGF expression by targeting STAT3 in H22 hepatocellular carcinoma cells.
Luo Y; He J; Tao X; Wang H; Fang Q; Guo S; Song C
Oncol Rep; 2018 Nov; 40(5):2806-2813. PubMed ID: 30132576
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
Yu G; Yao W; Xiao W; Li H; Xu H; Lang B
J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284
[TBL] [Abstract][Full Text] [Related]
31. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
[TBL] [Abstract][Full Text] [Related]
33. Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling.
Zhang JF; He ML; Fu WM; Wang H; Chen LZ; Zhu X; Chen Y; Xie D; Lai P; Chen G; Lu G; Lin MC; Kung HF
Hepatology; 2011 Dec; 54(6):2137-48. PubMed ID: 21809363
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of microRNA-495 improves the intestinal mucosal barrier function by targeting STAT3 via inhibition of the JAK/STAT3 signaling pathway in a mouse model of ulcerative colitis.
Chu XQ; Wang J; Chen GX; Zhang GQ; Zhang DY; Cai YY
Pathol Res Pract; 2018 Jan; 214(1):151-162. PubMed ID: 29129493
[TBL] [Abstract][Full Text] [Related]
35. MiR-506 inhibits cell proliferation, invasion, migration and epithelial-to-mesenchymal transition through targeting RWDD4 in human bladder cancer.
Hou Y
Oncol Lett; 2019 Jan; 17(1):73-78. PubMed ID: 30655740
[TBL] [Abstract][Full Text] [Related]
36. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
37. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
38. BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway.
Jiang N; Liao Y; Wang M; Wang Y; Wang K; Guo J; Wu P; Zhong B; Guo T; Wu C
J Exp Clin Cancer Res; 2021 Dec; 40(1):378. PubMed ID: 34852826
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21.
Zhang Q; Miao S; Han X; Li C; Zhang M; Cui K; Xiong T; Chen Z; Wang C; Xu H
Cell Death Dis; 2018 Sep; 9(10):960. PubMed ID: 30237499
[TBL] [Abstract][Full Text] [Related]
40. microRNA-30a inhibits the liver cell proliferation and promotes cell apoptosis through the JAK/STAT signaling pathway by targeting SOCS-1 in rats with sepsis.
Yuan FH; Chen YL; Zhao Y; Liu ZM; Nan CC; Zheng BL; Liu XY; Chen XY
J Cell Physiol; 2019 Aug; 234(10):17839-17853. PubMed ID: 30972748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
